| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | GILD | Common Stock | Options Exercise | $0 | +2.73K | +8.37% | $0.00 | 35.3K | 06 Feb 2022 | Direct | F1 |
| transaction | GILD | Common Stock | Tax liability | -$66.2K | -1.04K | -2.93% | $63.90 | 34.3K | 06 Feb 2022 | Direct |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | GILD | Restricted Stock Unit | Options Exercise | -2.73K | -10.59% | 23K | 06 Feb 2022 | Common Stock | 2.73K | Direct | F1, F2 |
| Id | Content |
|---|---|
| F1 | Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. |
| F2 | The restricted stock units have a four year vesting schedule. 25% vest on the anniversary of the date of grant until fully vested. |